PFBT
CRMD icon

Parkside Financial Bank & Trust’s CorMedix CRMD Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7 Hold
1
– – ﹤0.01% 2684
2025
Q4 		$12 Hold
1
– – ﹤0.01% 2674
2025
Q3 		$12 Sell
1
-35
-97% -$423 ﹤0.01% 2698
2025
Q2 		$444 Sell
36
-29
-45% -$320 ﹤0.01% 2603
2025
Q1 		$400 Buy
+65
New +$673 ﹤0.01% 2539

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Parkside Financial Bank & Trust's CRMD Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its CorMedix (CRMD) position steady in Q1 2026 at 1 share worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Parkside Financial Bank & Trust first reported a position in CRMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $444 in Q2 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Parkside Financial Bank & Trust held 1 share of CorMedix worth $7 as of Q1 2026.
  • Parkside Financial Bank & Trust left its CorMedix share count unchanged in Q1 2026.
  • CorMedix made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2684 holding.
  • Parkside Financial Bank & Trust first reported a position in CorMedix in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's CorMedix position peaked at $444 in Q2 2025.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.